| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 473,8 k € | -10.1% | 527,0 k € | +21.1% | 435,1 k € | -4.4% | 455,4 k € | +14.3% | 398,2 k € | -4.8% | 418,3 k € | +0.3% | 416,9 k € | +29.7% | 321,5 k € | +10.2% | 291,8 k € | -17.6% | 354,0 k € | -7.0% | 380,7 k € | +4.6% | 364,1 k € | -12.5% | 416,0 k € | +3.7% | 401,1 k € | +8.9% | 368,4 k € | +0.8% | 365,5 k € | +1.9% | 358,7 k € | +20.1% | 298,6 k € | +11.8% | 267,1 k € | -10.5% | 298,5 k € | |
| EBITDA | 469,5 k € | -10.2% | 522,7 k € | +21.3% | 431,0 k € | -4.6% | 451,6 k € | +15.5% | 391,1 k € | -4.9% | 411,1 k € | +2.6% | 400,9 k € | +28.1% | 313,0 k € | +10.3% | 283,8 k € | -16.4% | 339,3 k € | +32.7% | 255,8 k € | +32.6% | 192,9 k € | -22.0% | 247,1 k € | +2.7% | 240,6 k € | +16.6% | 206,4 k € | -14.2% | 240,7 k € | +0.0% | 240,6 k € | +22.4% | 196,6 k € | +31.0% | 150,1 k € | -27.1% | 205,9 k € | |
| Operating profit | 462,3 k € | -10.2% | 514,9 k € | +27.5% | 403,8 k € | -5.1% | 425,4 k € | +16.7% | 364,5 k € | -5.8% | 387,0 k € | +4.1% | 371,7 k € | +32.5% | 280,6 k € | +15.5% | 242,9 k € | -15.9% | 288,8 k € | +40.3% | 205,8 k € | +45.6% | 141,3 k € | -27.9% | 196,1 k € | +33.0% | 147,4 k € | +42.6% | 103,4 k € | -35.7% | 160,8 k € | -2.3% | 164,5 k € | +218.8% | 51,6 k € | +694.8% | 6,5 k € | -94.4% | 115,3 k € | |
| Profit/loss | 455,3 k € | -9.9% | 505,4 k € | +27.7% | 395,7 k € | -6.2% | 422,1 k € | +17.5% | 359,2 k € | -6.9% | 385,9 k € | -7.0% | 415,0 k € | +26.7% | 327,4 k € | +10.8% | 295,4 k € | -14.1% | 343,9 k € | +25.4% | 274,2 k € | +33.6% | 205,2 k € | -19.0% | 253,1 k € | +59.0% | 159,2 k € | +13.6% | 140,1 k € | -32.9% | 208,8 k € | +29.8% | 160,9 k € | +95.5% | 82,3 k € | +169.7% | 30,5 k € | -49.3% | 60,1 k € | |
| Equity | 823,4 k € | -2.3% | 843,1 k € | -2.3% | 862,7 k € | -3.3% | 892,0 k € | -4.1% | 929,9 k € | -2.2% | 950,8 k € | -0.9% | 959,9 k € | +0.0% | 959,8 k € | +0.1% | 958,9 k € | +0.0% | 958,5 k € | +0.1% | 957,6 k € | +0.0% | 957,4 k € | +0.9% | 948,5 k € | +2.3% | 927,4 k € | +1.8% | 910,6 k € | +1.5% | 897,4 k € | +2.4% | 876,4 k € | +1.3% | 865,5 k € | +1.4% | 853,2 k € | +1.2% | 842,7 k € | |
| Total assets | 1,8 M € | -3.5% | 1,8 M € | -1.4% | 1,8 M € | -1.3% | 1,9 M € | +4.8% | 1,8 M € | -5.9% | 1,9 M € | -3.8% | 2,0 M € | +2.4% | 1,9 M € | -3.6% | 2,0 M € | -1.7% | 2,0 M € | +1.2% | 2,0 M € | +3.6% | 1,9 M € | -1.6% | 2,0 M € | -1.6% | 2,0 M € | -5.4% | 2,1 M € | -4.2% | 2,2 M € | -2.3% | 2,3 M € | +1.4% | 2,2 M € | +0.4% | 2,2 M € | -1.7% | 2,3 M € | |
| Cash | 185,4 k € | -28.5% | 259,3 k € | -9.2% | 285,6 k € | +27.8% | 223,5 k € | +30.9% | 170,7 k € | -1.7% | 173,6 k € | -1.5% | 176,3 k € | -4.1% | 183,8 k € | -14.7% | 215,4 k € | -24.6% | 285,7 k € | +45.8% | 195,9 k € | -41.1% | 332,4 k € | +11.2% | 299,0 k € | -5.9% | 317,8 k € | +45.3% | 218,7 k € | -20.2% | 274,0 k € | -15.2% | 323,2 k € | +60.5% | 201,4 k € | -0.7% | 202,8 k € | -7.3% | 218,7 k € | |
| Debts | 930,3 k € | -4.3% | 972,4 k € | -0.1% | 973,6 k € | -0.1% | 974,6 k € | +14.6% | 850,5 k € | -9.8% | 942,5 k € | -6.5% | 1,0 M € | +4.8% | 961,4 k € | -6.8% | 1,0 M € | -3.3% | 1,1 M € | +2.4% | 1,0 M € | +6.6% | 977,4 k € | -3.8% | 1,0 M € | -5.0% | 1,1 M € | -10.9% | 1,2 M € | -8.0% | 1,3 M € | -5.3% | 1,4 M € | +1.7% | 1,4 M € | -0.3% | 1,4 M € | -3.9% | 1,4 M € | |
| Staff | — | — | — | — | — | — | — | — | — | 0,6 | 3,1 | 3,4 | 3,6 | 3,6 | 3,8 | 3,3 | 3,2 | 2,7 | 2,6 | 2,9 | ||||||||||||||||||||
Public limited company · Aalter · incorporated on 13/01/1983
Public limited company profitable and well capitalised. Cash position declining (-28.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK DEDEYNE is a Public limited company incorporated in 1983. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Aalter.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette